disulfiram has been researched along with ethambutol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Sobue, I | 1 |
| Weismann, K | 1 |
| Lessell, S | 1 |
| Manent, PJ; Perdriel, G | 1 |
3 review(s) available for disulfiram and ethambutol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Exogenous toxic neuropathy (author's transl)].
Topics: Acrylamides; Adolescent; Adult; Aged; Aldrin; Carbon Disulfide; Chloramphenicol; Clioquinol; DDT; Disulfiram; Endrin; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Nervous System Diseases; Phenytoin; Sulfonamides; Thalidomide; Thiamphenicol; Trichloroethylene; Vincristine | 1976 |
[Drug-induced dyschromatopsias].
Topics: Antimalarials; Brain Diseases; Color Perception; Color Perception Tests; Contraceptives, Oral; Digitalis Glycosides; Disulfiram; Ethambutol; Female; Humans; Methods; Monoamine Oxidase Inhibitors; Phenothiazines; Retinal Diseases; Santonin; Vision Disorders; Visual Pathways | 1982 |
8 other study(ies) available for disulfiram and ethambutol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Chelating drugs and zinc.
Topics: Animals; Chelating Agents; Disulfiram; Ethambutol; Humans; Organometallic Compounds; Oxyquinoline; Penicillamine; Phenytoin; Pyridines; Rats; Tetracycline; Zinc | 1986 |
Toxic metabolic disorders of myelin --ophthalmological features.
Topics: Adolescent; Adult; Aged; Amblyopia; Child; Child, Preschool; Chloramphenicol; Contraceptives, Oral, Hormonal; Cyanides; Demyelinating Diseases; Disulfiram; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Ethanol; Female; Humans; Hydroxyquinolines; Infant; Infant, Newborn; Male; Methanol; Middle Aged; Nicotiana; Optic Neuritis; Plants, Toxic | 1983 |